TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Kenvue said third-quarter 2026 net sales rose 3.2% to $3.8 billion, with gross profit up 4% to $2.3 billion. Skin health and beauty sales increased just 0.1%, including an organic decline, while hair care posted low double-digit organic growth. Kenvue did not provide full-year guidance because its proposed combination with Kimberly-Clark is pending.
Kenvue reported a 3.2% increase in third-quarter 2026 net sales to $3.8 billion, while its skin health and beauty business recorded only a 0.1% gain. The consumer health company also reported higher gross profit and cited growth in self-care, essential health and hair care, but did not issue full-year guidance while its proposed combination with Kimberly-Clark remains pending.
For the first nine months of 2026, Kenvue said net sales rose 3.6% to $11.7 billion, compared with $11.34 billion over the same period in 2025. Third-quarter gross profit increased 4% to $2.3 billion, from $2.2 billion a year earlier. The figures point to overall growth, but the company’s business lines did not perform evenly.
In skin health and beauty, sales increased 0.1% on a reported basis. Kenvue’s figures separate that result into a 0.5% organic sales decline and a 0.6% benefit from foreign currency. Hair care provided a stronger result: the company reported low double-digit organic sales growth, led by Rogaine. Kenvue said Rogaine recorded its fourth consecutive quarter of market-share gains.
The company also pointed to North American sun-care activity following last month’s launch of Neutrogena Cloud Tech featuring BEMT, or bemotrizinol. The source report describes it as the brand’s first sunscreen technology using the UV filter, which it says has received FDA approval. The launch was cited as part of Kenvue’s expansion of its sun-care business; the material provided does not give sales figures for the product.
Growth masks a beauty slowdown
The results show why Kenvue’s overall sales growth does not tell the whole story for its beauty-facing brands. Skin health and beauty was almost flat on a reported basis, and its organic sales fell, even as the company recorded broader gains. Currency added 0.6 percentage points to that segment’s reported result, so the reported increase and underlying organic trend differ.
For investors, retail customers and brand watchers, the contrast between soft organic beauty sales and stronger hair-care performance offers a more detailed read on the company’s quarter than the consolidated sales figure alone. Kenvue’s comments on Rogaine and the Neutrogena launch indicate areas it is emphasizing, but the report does not establish that the new sunscreen product has already materially affected results.
The absence of forward guidance also limits what readers can infer about the rest of the year. With a proposed Kimberly-Clark transaction pending, Kenvue has not supplied its usual outlook in this update. That leaves the reported quarter as a snapshot rather than a company forecast for upcoming sales or earnings.
Products Worth Considering
Therabody Theragun Relief Massage Gun, 3-Speed, Navy
Garmin Forerunner 70 GPS Running Smartwatch, 43 mm, Black
Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor
As an affiliate, we earn on qualifying purchases.
A quarter during a pending deal
Kenvue was separated from Johnson & Johnson and operates consumer health and personal-care brands including Neutrogena, Aveeno, OGX and Listerine. The source report says Kimberly-Clark announced an agreement to acquire Kenvue in a $48.7 billion deal the previous year. The proposed combination would bring Kenvue’s health and beauty portfolio under the same corporate umbrella as Kimberly-Clark’s personal-care brands.
Kenvue also began a strategic review in July 2025, according to the report, after falling sales and job cuts. The initiative was described as aiming to change the operating model, transform the supply chain, reduce complexity, improve efficiency and strengthen core capabilities. Chief Executive Kirk Perry said the company remained on track with a business transformation that began the prior year. The report does not provide a detailed update on savings or milestones achieved.
“We are pleased to have delivered our fourth consecutive quarter of net and organic sales growth, with strong performance in self-care and essential health, along with margin expansion and strong cash generation.”
— Kirk Perry, Kenvue CEO
Outlook and deal timing remain open
Kenvue did not provide forward-looking guidance in this quarterly update, citing the pending Kimberly-Clark transaction. The source material does not specify when the deal is expected to close, whether any regulatory or other conditions remain, or whether the companies have announced a revised timetable.
The report also does not give detailed sales or profit figures for individual brands, nor does it quantify the financial contribution from the Neutrogena Cloud Tech launch. Kenvue’s reported 0.1% skin health and beauty increase is accompanied by an organic decline and a currency benefit, but the source does not explain demand trends by market or product. Those details remain unavailable in the material provided.
Awaiting deal and guidance updates
The next major milestones are further updates on the proposed Kimberly-Clark combination and Kenvue’s subsequent financial reporting. Until the transaction’s status or timing changes, the company has said it will not provide forward-looking guidance in this update. Investors and customers will also be watching whether Kenvue’s beauty segment returns to organic growth and whether hair-care momentum continues; the current report does not forecast either outcome.
Key Questions
How much did Kenvue’s sales increase in Q3 2026?
Kenvue reported that net sales rose 3.2% to $3.8 billion in the third quarter of 2026.
How did Kenvue’s skin health and beauty business perform?
Reported sales increased 0.1%. The company’s figures included a 0.5% organic decline and a 0.6% benefit from foreign currency.
Which area led Kenvue’s reported growth?
Kenvue said hair care delivered low double-digit organic sales growth, led by Rogaine, which recorded its fourth consecutive quarter of market-share gains.
Why did Kenvue not provide full-year guidance?
The company withheld forward-looking guidance in the quarterly update because its proposed combination with Kimberly-Clark is pending.
What is known about the Neutrogena Cloud Tech launch?
The source report says Kenvue launched Neutrogena Cloud Tech featuring bemotrizinol in North America the month before the update. It provides no product-specific sales figures or evidence of the launch’s financial impact.
Source: cosmeticsbusiness.com
